ClinicalTrials.gov
public full text
Public Domain
Low-Dose Naltrexone For ME/CFS: Dose-Finding
This exploratory clinical trial tests low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A remote trial approach is used, with eligibility open to the state of Alabama.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recovery Initiation and Management After Overdose (RIMO) Experiment#843534
- Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd#1059151
- 21 CFR Part 357 — Miscellaneous Internal Drug Products for Over-the-Counter Human Use#506839
- Predictors of Intravenous Ketamine Response in TRD#842743
- Estimating the Need for Naloxone Distribution from United States Emergency Departments#123353
Record · ID 832258
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive